Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to provide written consent to participate.
- People aged between 18 and 80 years old.
- People who are able to read and understand German.
- For the patient groups: people with a suspected or confirmed diagnosis of Alzheimer's disease, mild cognitive impairment (MCI), or depression with memory or thinking difficulties, based on a clinical assessment.
Who may not be able to join:
- People who are currently experiencing serious thoughts of suicide (confirm with trial site for how this is assessed).
- People whose psychiatric medications have been changed within the last 4 weeks.
- People who have ever been diagnosed with a psychotic disorder (such as schizophrenia or related conditions).
- People who do not have the mental capacity to give informed consent to participate.
- People who have ever been diagnosed with bipolar disorder.
- People who are currently misusing alcohol or other substances in a harmful way.
- People who have a diagnosis of Parkinson's disease or a related condition.
- People who have a diagnosis of multiple sclerosis.
- People who have had a stroke within the last 12 months.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Victor I. Spoormaker, PhD, Max-Planck-Institute of Psychiatry
Phone: 089-30622-1402
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Task-evoked pupil dilation during N-Back
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.